Hans-Erik Johansson
Overview
Explore the profile of Hans-Erik Johansson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
386
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosqvist F, Cedernaes J, Mora A, Friden M, Johansson H, Iggman D, et al.
Am J Clin Nutr
. 2024 Apr;
120(1):121-128.
PMID: 38636844
Background: Fatty acids may influence lean tissue volume and skeletal muscle function. We previously reported in young lean participants that overfeeding PUFA compared with SFA induced greater lean tissue accumulation...
2.
Aldenback E, Johansson H
J Obes
. 2021 Jul;
2021:6647328.
PMID: 34327018
Abdominal obesity is associated with hypertension, increased fasting glucose, HbA1c, and cholesterol. Body mass index (BMI) is frequently used to measure and define obesity and as inclusion criteria for bariatric...
3.
Rosqvist F, Orho-Melander M, Kullberg J, Iggman D, Johansson H, Cedernaes J, et al.
Front Nutr
. 2020 Dec;
7:606004.
PMID: 33344496
Saturated fat (SFA) has consistently been shown to increase liver fat, but the response appears variable at the individual level. Phenotypic and genotypic characteristics have been demonstrated to modify the...
4.
Rasmussen E, Hallberg P, Baranova E, Eriksson N, Karawajczyk M, Johansson C, et al.
Pharmacogenomics J
. 2020 Feb;
20(6):770-783.
PMID: 32080354
Angioedema in the mouth or upper airways is a feared adverse reaction to angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) treatment, which is used for hypertension, heart failure...
5.
Johansson H, Edholm D, Kullberg J, Rosqvist F, Rudling M, Straniero S, et al.
Nutr Diabetes
. 2019 Nov;
9(1):34.
PMID: 31685793
Energy restriction reduces liver fat, improves hepatic insulin resistance and lipid metabolism. However, temporal data in which these metabolic improvements occur and their interplay is incomplete. By performing repeated MRI...
6.
Rosqvist F, Kullberg J, Stahlman M, Cedernaes J, Heurling K, Johansson H, et al.
J Clin Endocrinol Metab
. 2019 Aug;
104(12):6207-6219.
PMID: 31369090
Context: Saturated fatty acid (SFA) vs polyunsaturated fatty acid (PUFA) may promote nonalcoholic fatty liver disease by yet unclear mechanisms. Objective: To investigate if overeating SFA- and PUFA-enriched diets lead...
7.
Haenni A, Nilsen I, Johansson H
Surg Obes Relat Dis
. 2018 Mar;
14(5):576-582.
PMID: 29567058
Background: Low circulating magnesium concentrations predict cardiovascular and all-cause mortality in patients with type 2 diabetes (T2D). Epidemiologic and clinical studies have indicated lower extra- and intracellular magnesium concentrations in...
8.
Johansson H, Wahlen A, Aldenback E, Haenni A
Obes Surg
. 2017 Dec;
28(6):1526-1531.
PMID: 29222767
Background: Obesity is associated with chronic inflammation, liver steatosis and increased liver enzymes such as gamma-glutamyltransferase (GGT) and alanine aminotransferase (ALT), markers for non-alcoholic fatty liver disease (NAFLD) and liver...
9.
Wahlen A, Haenni A, Johansson H
Diabetes Metab Syndr Obes
. 2017 May;
10:151-154.
PMID: 28496346
Objective: We aimed to investigate the prevalence of B12 deficiency in metformin-treated, morbidly obese, type 2 diabetes mellitus (T2DM) patients, compared to morbidly obese controls, as well as to evaluate...
10.
Hallberg P, Persson M, Axelsson T, Cavalli M, Norling P, Johansson H, et al.
Pharmacogenomics
. 2017 Jan;
18(3):201-213.
PMID: 28084903
Aim: We conducted a genome-wide association study on angiotensin-converting enzyme inhibitor-induced cough and used our dataset to replicate candidate genes identified in previous studies. Patients & Methods: A total of...